Smart Pills Market To Reach $3.64 Billion By 2030 | CAGR 11.3%

December 2024 | Report Format: Electronic (PDF)

Smart Pills Market Growth & Trends

The global smart pills market size is estimated to reach USD 3.64 billion by 2030, registering to grow at a CAGR of 11.3% from 2024 to 2030 according to a new report by Grand View Research, Inc. An increase in prevalence of diseases such as colorectal cancer and gastrointestinal disorders, expansion in the geographical reach of major players, rising cancer screening awareness programs, and expeditious FDA approvals are prime factors that are expected to drive the market growth over the forecast period.

Smart pills have transformed the landscape of small bowel, colon, and gastrointestinal endoscopy by providing a non-invasive and accurate method for visualizing distal duodenum, jejunum, small bowel, colon, gastrointestinal, and ileum. Smart pills are mostly used for screening and treatment of diseases such as colorectal cancer, gastroparesis, gastric ulcers, and gastroesophageal disorders.

Consumers of smart pills mostly include geriatric population, immobile patients, and patients with paralysis. Considering the steady rise in geriatric population around the globe, the demand for advanced medical devices will also increase as they offer a degree of convenience to patients. Established players in this market are enhancing their portfolio by upgrading existing devices. On the other hand, new players are focused on capturing emerging economies with breakthrough products that are both advanced and affordable.


key Request a free sample copy or view report summary: Smart Pills Market Report


Smart Pills Market Report Highlights

  • Capsule endoscopy dominated the market and accounted for the largest revenue share of 54.1% attributed to the painless procedure of diagnosing gastrointestinal disorders.

  • Celiac disease led the market and accounted for the largest revenue share 2023 driven by the increasing prevalence of gastrointestinal disorders and chronic diseases, such as cancer and diabetes, which necessitate innovative diagnostic and treatment solutions.

  • Small intestine dominated the market and held the largest revenue share in 2023 driven by the rising incidence of small intestine disorders, such as Crohn's and celiac diseases.

  • Outpatient facilities dominated the market with a share of 53.3% in 2023 owing to the rising demand for appropriate medicines and initiatives by governments to promote automated medication technologies in healthcare to minimize errors and risks.

  • The North America smart pills market dominated the global market and accounted for the largest revenue share of 37.5% in 2023.

Smart Pills Market Segmentation

Grand View Research has segmented the global smart pills market based on application, disease indication, target area, end-use, and region:

Smart Pills Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Capsule Endoscopy

  • Drug Delivery

  • Vital Sign Monitoring

Smart Pills Disease Identification Outlook (Revenue, USD Million, 2018 - 2030)

  • Occult GI Bleeding

  • Crohn’s Disease

  • Small Bowel Tumors

  • Celiac Disease

  • Inherited Polyposis Syndromes

  • Neurological Disorders

  • Other Disease Indications

Smart Pills Target Area Outlook (Revenue, USD Million, 2018 - 2030)

  • Esophagus

  • Small Intestine

  • Large Intestine

  • Stomach

Smart Pills End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Outpatient Facilities

Smart Pills Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

List of Key Players in the Smart Pills Market

  • Medtronic

  • Otsuka Holdings Co., Ltd.

  • Olympus Corporation

  • CapsoCam Plus

  • Pentax Medical

  • JINSHAN Science & Technology (Group) Co., Ltd.

  • Check-Cap Ltd.

  • etectRx

  • INTROMEDIC

  • Shenzen Jifu Medical Technology Co., Ltd

  • BodyCapUSA

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.